Retiring Covidien CEO to chair Haemonetics board
This article was originally published in Clinica
Executive Summary
Blood management specialist Haemonetics has appointed Richard Meelia chairman of its board of directors. Mr Meelia is currently CEO of Covidien but is expected to retire from this position in July (www.clinica.co.uk, 16 March 2011). He has led Covidien since 1995 and has nearly 40 years' experience in the healthcare industry. He is not new to Haemonetics, having served on the Braintree, Massachusetts firm's board between 2005-2009; he resigned to focus on his role as Covidien's CEO.